Dashboard
Manage Tickers

ALPMYAstellas Pharma Inc.


$ -0.10 (-1.03 %)    

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 445.88 $ 1.10 (0.25 %)
DIA $ 395.58 $ 1.12 (0.28 %)
SPY $ 523.16 $ 2.25 (0.43 %)
TLT $ 90.86 $ 0.51 (0.56 %)
GLD $ 218.12 $ 1.87 (0.86 %)
$ 9.62
-- x --
-- x --
-- - --
$ 9.15 - $ 16.91
419,288
na
0
$ 0.51
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles
Reported Earlier, Astellas And Poseida The...
05/02/2024 07:29:44

- Leverages Poseida's proprietary allogeneic CAR-T platform to develop innovative convertibleCAR® programs targeting solid ...

Core News & Articles
Reported Earlier, Astellas' XTANDI (Enzalu...
04/24/2024 06:23:57

TANDI is now the first and only novel hormone therapy available for the treatment of high-risk biochemical recurrent non-meta...

Core News & Articles
Reported Earlier, Astellas Initiated Phase...
03/04/2024 06:47:32

In Japan, two Phase 3 clinical studies are underway. STARLIGHT 2 is evaluating the efficacy and safety of fezolinetant once-dai...

Core News & Articles
Astellas Submits Supplemental New Drug App...
01/31/2024 06:34:20

– Pivotal trial found the enfortumab vedotin plus pembrolizumab combination significantly extended overall and progression-free...

upward-trajectory-for-biotechpharma-ma-sector-trends-towards-pre-pandemic-levels-forecasts-positive-for-2024
Upward Trajectory For Biotech/Pharma M&A: ...
12/29/2023 12:04:52

According to the Global Data report, the pharma sector in Q3 2023 witnessed deals worth $28 billion, down 28% from the $54 bill...

Core News & Articles
Elpiscience And Astellas Announce Research...
12/28/2023 06:58:10

Core News & Articles
European Medicines Agency Recommends Astel...
12/18/2023 06:19:05

Core News & Articles
FDA Approves Expanded Indication For KEYTR...
12/16/2023 23:38:35

Approval is based on results from the Phase 3 KEYNOTE-A39 trial, which demonstrated a superior overall survival benefit with KE...

Core News & Articles
Reported Earlier, Astellas' VEOZA™ Has Bee...
12/11/2023 07:17:48

Core News & Articles
Astellas Pharma And Pfizer Announced FDA A...
11/17/2023 08:52:46

Core News & Articles
Seagen And Astellas Announced Groundbreaki...
10/22/2023 14:48:25

Seagen Inc. (NASDAQ:SGEN) and Astellas Pharma Inc. (TSE:4503 “Astellas”) today announced results from the Phase 3 EV-302 clinic...

mercks-best-selling-cancer-drug-meets-one-goal-in-late-stage-bladder-cancer-study
Merck's Best Selling Cancer Drug Meets One...
10/05/2023 13:35:57

Merck & Co Inc (NYSE: MRK) announced that the Phase 3 AMBASSADOR (A031501) trial (KEYNOTE-123) evaluating Keytruda met one ...

why-is-seagen-stock-trading-higher-today
Why Is Seagen Stock Trading Higher Today?
09/22/2023 15:05:52

Seagen Inc (NASDAQ: SGEN) and Astellas Pharma Inc (OTC: ALPMF) (OTC: 

whats-going-on-with-neurology-focused-taysha-gene-therapies-stock-today
What's Going On With Neurology Focused Tay...
09/20/2023 18:12:43

Astellas Pharma Inc (OTC: ALPMY) (OTC: ALPMF) has elected 

from-ai-to-obesity-drugs---global-pharma-has-700b-for-ma-and-investments-goldman-sachs
From AI to Obesity Drugs - Global Pharma H...
07/07/2023 17:18:25

Goldman Sachs compiled research suggesting the global pharmaceutical sector has approximately $700 billion available for M&...

Core News & Articles
On July 6, At Special Meeting Iveric Bio I...
07/06/2023 17:07:18

- Reuters 

astellas-pharma-licenses-promising-gene-therapy-kt430-from-kate-therapeutics-amidst-clinical-hurdles
Astellas Pharma Licenses Promising Gene Th...
06/08/2023 16:10:41

Astellas Pharma Inc (OTC: ALPMF) (OTC: ALPMY) decided to license and advance a gene therapy from Kate Therapeutics for a debili...

google-launches-tools-to-detect-fake-images-apple-may-encounter-delays-in-iphone-15-production-shake-shack-sees-activist-investor-proxy-fight-todays-top-stories
Google Launches Tools To Detect Fake Image...
05/15/2023 13:47:50

Bloomberg

astellas-menopause-drug-sores-fda-approval-after-regulatory-setback
Astellas' Menopause Drug Sores FDA Approva...
05/15/2023 10:57:13

The FDA on Friday approved Japanese drugmaker Astellas Pharma Inc’s (OTC: ALPMY) (OTC: ALPMF) Veozah (fezolinetant) for hot fla...

pfizer-astellas-xtandi-combo-therapy-cuts-risk-of-metastasis-death-in-prostate-cancer-by-58
Pfizer, Astellas' Xtandi Combo Therapy Cut...
05/01/2023 18:32:12

Astellas Pharma Inc (OTC: ALPMY) and Pfizer Inc (NYSE: PFE) announced 

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION